Phase 2CompletedAge-related condition
Melatonin and the Metabolic Syndrome (MetSyn)
Melatonin Supplementation and the Metabolic Syndrome: A Phase II Crossover Design Clinical Trial
- Sponsor
- Emory University (Academic or other)
- Enrollment
- 39 enrolled
- Conditions
- Metabolic Syndrome
- Interventions
- Melatonin; Placebo
- Ages
- adults, older adults
- Registry
- NCT01038921
Full record on ClinicalTrials.gov
From the registry
This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
Primary outcomes
- Metabolic Syndrome Components
History
Last registry update
Results first posted
Study completion
Primary completion
Registered
Started
Papers citing this trial
- Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial
Diabetology & metabolic syndrome